Prof. Dr. Halil Kavgacı

Formation et spécialisation

• Faculté de médecine de l’Université Atatürk — formation médicale.
• 1992 — Faculté de médecine de l’Université technique de la mer Noire — spécialisation en médecine interne.
• 2003 — Faculté de médecine de l’Université technique de la mer Noire — surspécialisation en oncologie médicale.

Expérience professionnelle

• Septembre 2001 – septembre 2004 — Directeur adjoint de l’Institut des sciences de la santé, Université technique de la mer Noire.
• Septembre 2004 – septembre 2009 — Coordinateur adjoint de la quatrième année, Faculté de médecine, Université technique de la mer Noire.
• Mars 2005 – octobre 2017 — Chef de la division d’oncologie médicale, Faculté de médecine, Université technique de la mer Noire.
• Décembre 2005 – février 2011 — Médecin-chef adjoint de l’hôpital Farabi, Université technique de la mer Noire.
• Septembre 2006 – janvier 2008 — Chef par intérim du département de radio-oncologie, Faculté de médecine, Université technique de la mer Noire.
• Octobre 2011 – octobre 2016 — Chef du département de médecine interne, Faculté de médecine, Université technique de la mer Noire.
• 2014 – 2016 — Président de la section du Croissant-Rouge turc de l’Université technique de la mer Noire.
• Avril 2015 – juillet 2019 — Médecin-chef de l’hôpital Farabi, Université technique de la mer Noire.

Affiliations professionnelles

• Société turque d’oncologie médicale (Tıbbi Onkoloji Derneği) — représentant de la région du Nord-Est, 2009–2011.
• Association du groupe d’oncologie médicale (Tıbbi Onkoloji Grubu Derneği).
• Association d’oncologie médicale de Trabzon (Trabzon Tıbbi Onkoloji Derneği) — fermée.
• Association turque pour la recherche et la lutte contre le cancer (Türk Kanser Araştırma ve Savaş Kurumu Derneği).
• Association de sénologie (Meme Derneği).
• Association du cancer du poumon (Akciğer Kanseri Derneği).
• Association des jeunes oncologues (Genç Onkologlar Derneği).
• Association d’oncologie académique (Akademik Onkoloji Derneği).

Domaines d’expertise

• Cancer du sein
• Cancer du poumon
• Cancers colorectaux
• Cancers gynécologiques
• Chimiothérapie
• Planification thérapeutique multidisciplinaire

Publications scientifiques

• NazimTurhal S., Dogan M., ESENDAĞLI G., Artac M., Korkmaz L., Coskun H. S., et al. The Relationship Between Plexin C1 Overexpression and Survival in Hepatocellular Carcinoma: a Turkish Oncology Group (TOG) Study. Journal of Gastrointestinal Cancer , vol.53, no.2, pp.356-362, 2022
• TOPÇU T., Kavgaci H., GUNALDI M., KOCOGLU H., AKYOL M., Mentese A., et al. The clinical importance of serum galectin-3 levels in breast cancer patients with and without metastasis.. Journal of cancer research and therapeutics , vol.14, 2018
• TOPCU T., Ozdemir F., Kavgaci H., GUNALDI M., KOCOGLU H., IMAMOGLU G., et al. The clinical importance of serum urokinase plasminogen activator receptor and carbonic anhydrase IX levels and the effect of anthracycline-based adjuvant chemotherapy on these biomarkers in breast cancer.. Journal of cancer research and therapeutics , vol.14, pp.608-613, 2018
• Topcu T. O., Kavgaci H., Özdemir F., Menteşe A., Örem A., Aydin F. Plasma Malondialdehyde and Ischemia-modified Albumin levels in breast cancer patients before and after adjuvant chemotherapy. BREAST , vol.32, 2017
• Arica D., TOPCU T. O., SELCUK L., YAYLI S., SEYMAN U., Fidan E., et al. Assessment of demodex presence in acne-like rash associated with cetuximab. CUTANEOUS AND OCULAR TOXICOLOGY , vol.36, no.3, pp.220-223, 2017
• MENTEŞE A., Fidan E., Alver A., DEMİR S., ÖZER YAMAN S., Sumer A., et al. Detection of autoantibodies against carbonic anhydrase I and II in the plasma of patients with gastric cancer. CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY , vol.42, no.1, pp.73-77, 2017
• AKSU ARICA D., OZTURK T. T., BAYKAL SELÇUK L., YAYLI S., SEYMAN Ü., FIDAN E., et al. Assessment of demodex presence in acne-like rash associated with cetuximab.. CUTANEOUS AND OCULAR TOXICOLOGY , vol.-, pp.1-4, 2016
• Ercelep O., Topcu T. O., Bayoglu I. V., Ekinci A. S., Koca S., Kavgaci H., et al. Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology. TUMOR BIOLOGY , vol.37, no.9, pp.12033-12038, 2016
• BEYHUN N. E., ÇAN G., Tiryaki A., Karakullukcu S., Bulut B., Yesilbas S., et al. Validity and Reliability of the Turkish Version of Needs Based Biopsychosocial Distress Instrument for Cancer Patients (CANDI). IRANIAN RED CRESCENT MEDICAL JOURNAL , vol.18, no.6, 2016
• Bahat Z., Kandaz M., Memıs Y. H., Canyılmaz E., Kavgacı H., Yöney A. Multiple primary malignant neoplasms from Eastern Black Sea Region of Turkey: Single center experience Türkiye doğu karadeniz bölgesi’nde multipl primer malign neoplaziler: Tek merkez deneyimi. Nobel Medicus , vol.12, no.2, pp.13-19, 2016
• BAHAT Z., KANDAZ M., Memis Y., CANYILMAZ E., Kavgaci H., Yoney A. MULTIPLE PRIMARY MALIGNANT NEOPLASMS FROM EASTERN BLACK SEA REGION OF TURKEY: SINGLE CENTER EXPERIENCE. NOBEL MEDICUS , vol.12, no.2, pp.13-19, 2016
• Bilici A., Ozturk T., Turkmen E., Odabas H., Cihan S., Selcukbiricik F., et al. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology. WORLD JOURNAL OF UROLOGY , vol.33, no.10, pp.1613-1622, 2015
• TOPCU T. O., Kavgaci H., CANYILMAZ E., ÖREM A., YAMAN H., US D., et al. The effect of adjuvant chemotherapy on plasma TAT and F 1+2 levels in patients with breast cancer. BIOMEDICINE & PHARMACOTHERAPY , vol.73, pp.19-23, 2015
• Abali H., ÇELİK İ., Karaca B., Turna H., Saglam E. K., Akman T., et al. Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study. JOURNAL OF BUON , vol.20, no.4, pp.1137-1141, 2015
• Yildiz B., FIDAN E., ÖZDEMİR F., SEZEN O., Kavgaci H., AYDIN F. Clinicopathological Characteristics of Triple-negative Breast Cancers in the Northeast Region of Turkey. BALKAN MEDICAL JOURNAL , vol.31, no.2, pp.126-131, 2014
• FIDAN E., MENTEŞE A., ÖZDEMİR F., DEĞER O., Kavgaci H., KARAHAN S. C., et al. Diagnostic and prognostic significance of CA IX and suPAR in gastric cancer. MEDICAL ONCOLOGY , vol.30, no.2, 2013
• Fidan E., Kavgaci H., ÖREM A., YILMAZ M., Yildiz B., FIDAN S., et al. Thrombin activatable fibrinolysis inhibitor and thrombin-antithrombin-III-complex levels in patients with gastric cancer. TUMOR BIOLOGY , vol.33, no.5, pp.1519-1525, 2012
• ÖZDEMİR F., Kavgaci H., OVALI E., YILMAZ M., YILDIZ B., AYDIN F. THE EFFECTS OF FARNESYLTRANSFERASE INHIBITOR L-744,832 AND RADIOTHERAPY ON H-RAS+(SVR A221A) CELL LINE. NOBEL MEDICUS , vol.8, no.3, pp.76-80, 2012
• Fidan E., Fidan M., Ozdemir F., Kavgaci H., Aydin F. Phenytoin- and cranial radiotherapy-induced toxic epidermal necrolysis treated with combination therapy: systemic steroid and intravenous immunoglobulin. MEDICAL ONCOLOGY , vol.29, no.2, pp.686-689, 2012
• Fidan E., YILDIZ B., Kavgaci H., Ozdemir F., Aydin F. Effects of zoledronic acid and ibandronic acid on renal functions and calcium, phosphorus and alkaline phosphatase levels in breast cancer patients with bone metastases: a retrospective analysis. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.16, no.2, pp.176-178, 2012
• FİDAN E., KAVGACI H. Metastatik Meme Kanserinde Hormonal Tedavi. Türkiye Klinikleri Tıbbi Onkoloji Özel Sayı , 2012 (Hakemli Dergi)
• Fidan E., Menteşe A., Kavgaci H., Örem A., Fidan S., Uzun A., et al. Increased ischemia-modified albumin levels in patients with gastric cancer. NEOPLASMA , vol.59, no.4, pp.393-397, 2012
• Buyukcelik A., Demirkazik A., YALÇIN B., Dogan M., Kavgaci H., COBAN S., et al. Albumin Infusion is not Beneficial in Hypoalbuminemic End-Stage Cancer Patients: A Matched-Pair Analysis. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.22, no.4, pp.213-219, 2012
• MENTEŞE A., Fidan E., Sumer A. U., KARAHAN S. C., SÖNMEZ M., Altay D. U., et al. Is SCUBE 1 a new biomarker for gastric cancer?. CANCER BIOMARKERS , vol.11, no.5, pp.191-195, 2012
• Fidan E., YILDIZ B., ÖZDEMİR F., UCAR U., Kavgaci H., OREM A., et al. Serum levels of 25-OH vitamin D, folic acid and testosterone in patients with breast cancer: a case control study. ASIAN BIOMEDICINE , vol.5, no.5, pp.663-667, 2011
• ÖZDEMİR F., OZDEMIR S., TOPBAŞ M., YILDIZ B., Fidan E., Kavgaci H., et al. THE EFFECTS OF PRENATAL FACTORS ON THE DEVELOPMENT OF NON-SMALL CELL LUNG CANCER. NOBEL MEDICUS , vol.7, no.3, pp.41-45, 2011
• AYDIN F., AKAGUN T., YILDIZ B., FIDAN E., OZDEMIR F., Kavgaci H. Clinicopathologic characteristics and BRCA-1/BRCA-2 mutations of Turkish patients with breast cancer. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.112, no.9, pp.521-523, 2011
• Kavgaci H., YILDIZ B., KARAGULLE M., FIDAN E., ÇOBANOĞLU Ü., ÖZDEMİR F., et al. Metastatic Malignant Melanoma of The Stomach in an Oculocutaneous Albino Patient: First Case. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.21, no.2, pp.120-123, 2011
• Fidan E., Fidan S., Yildiz B., Durmuş İ., Kavgaci H., Özdemir F., et al. Bolus fluorouracil induced syncope and pulseless ventricular tachycardia: a case report. HIPPOKRATIA , vol.15, no.1, pp.93-95, 2011
• ÖZDEMİR F., ERSOY K., TOPBAŞ M., FİDAN E., YILDIZ B., Kavgaci H., et al. The effect of prenatal factors on the development of colon cancer. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.112, no.6, pp.342-345, 2011
• YILDIZ B., REIS A., Fidan E., ÖZDEMİR F., Kavgaci H., AYDIN F. Metastases from Rectum and Thyroid Cancers in Same Cervical Lymph Node - A Case Report. KOREAN JOURNAL OF PATHOLOGY , vol.44, no.5, pp.551-553, 2010
• YILDIZ B., Kavgaci H., Fidan E., GUNGOR E., ERSOZ H. O., ÖZDEMİR F., et al. Oral fluoropyrimidine-induced severe hyperlipidemia. ASIAN BIOMEDICINE , vol.4, no.4, pp.627-630, 2010
• Fidan E., YILDIZ B., YILMAZ M., ÖZDEMİR F., Kavgaci H., AYDIN F. Increased Circulating Vitamin D and Testosterone Levels in Patients with Cancer. HEALTHMED , vol.4, no.4, pp.1072-1075, 2010
• Kavgaci H., YILDIZ B., ÇOBANOĞLU Ü., FIDAN E., ÖZDEMİR F., AYDIN F. Laryngeal Squamous Cell Carcinoma with Knee and Heel Skin Metastases: A Case Report. ACTA DERMATOVENEROLOGICA CROATICA , vol.18, no.1, pp.32-34, 2010
• Kavgaci H., YILDIZ B., FİDAN E., REIS A., ÖZDEMİR F., ÇOBANOĞLU Ü., et al. The effects of E-cadherin and bcl-2 on prognosis in patients with breast cancer. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.111, no.9, pp.493-497, 2010
• YILDIZ B., ERSÖZ Ş., FIDAN E., FIDAN S., ÖZDEMİR F., Kavgaci H., et al. Classic Kaposi's Sarcoma with Multiple Visceral Organ Involvement Presenting with Gastrointestinal Bleeding. HEALTHMED , vol.4, no.4, pp.1103-1106, 2010
• YILDIZ B., ERSÖZ Ş., FİDAN E., FİDAN S., ÖZDEMİR F., KAVGACI H., et al. Classic Kaposi’xxs Sarcoma with Multiple Visceral Organ Involvement Presenting with Gastrointestinal BleedingYıldız B, Ersoz S, Fidan E, Fidan S, Ozdemır F, Kavgacı H, Aydın F.. HEALTHMED , vol.4, no.4, pp.1103-1106, 2010
• Kavgaci H., SÖNMEZ M., Cobanoglu U., ALİOĞLU Z., YILDIZ B., ÖZDEMİR F., et al. Paraneoplastic Peripheral Neuropathy Preceding the Diagnosis of Hodgkin's Lymphoma: Differential Diagnosis. TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.29, no.5, pp.1342-1345, 2009
• ÖZDEMİR F., Beşir A., ERSOY K., FİDAN E., YILDIZ B., Kavgaci H., et al. The effect of prenatal factors on the development of rectal cancer. Nobel Medicus , vol.5, no.3, pp.70-73, 2009
• KOŞUCU P., TEKİNBAŞ C., EROL M., SARI A., Kavgaci H., ÖZTUNA F., et al. Mediastinal Lymph Nodes: Assessment With Diffusion-Weighted MR Imaging. JOURNAL OF MAGNETIC RESONANCE IMAGING , vol.30, no.2, pp.292-297, 2009
• ÖZDEMİR F., DENİZ Ö., KAYNAR R. K., ARSLAN M., KAVGACI H., YILDIZ B., et al. The Effects of Melatonin on Human Hepatoma (Hep G2) Cell Line. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.110, pp.276-279, 2009
• SÖNMEZ M., ARSLAN M., ÇOBANOĞLU Ü., Kavgaci H., OZBAS H. M., AYDIN F., et al. Association of gastrointestinal stromal tumor and acute myeloid leukemia preceded by myelodysplastic syndrome with refractory anemia. TUMORI J , vol.95, no.2, pp.240-242, 2009
• YILDIZ B., ÖZDEMİR F., ÇOBANOĞLU Ü., Kavgaci H., FIDAN E., AYDIN F. Clear Cell Hidradenoma of the Gluteal Region: A Case Report. ACTA DERMATOVENEROLOGICA CROATICA , vol.17, no.2, pp.144-146, 2009
• ÖZDEMİR F., DENİZ O., KAYNAR K., ARSLAN M., Kavgaci H., YILDIZ B., et al. The effects of melatonin on human hepatoma (Hep G2) cell line.. Bratislavske lekarske listy , vol.110, no.5, pp.276-9, 2009
• ÖZDEMİR F., BEŞİR A., ERSOY K., FİDAN E., YILDIZ B., KAVGACI H., et al. The Effects of Prenatal Factors on the Development of Rectal Cancer.. Nobel Medicus , 2009
• Ozsu S. S., EROL M. M., ÖZTUNA F., ERSÖZ Ş., Kavgaci H., AKSOY H. Z. Endobronchial metastasis from testicular seminoma. MEDICAL PRINCIPLES AND PRACTICE , vol.17, no.6, pp.493-495, 2008
• OZDEMIR F., AKDOGAN R. A., AYDIN F., REIS A., Kavgaci H., GUL S., et al. The effects of VEGF and VEGFR-2 on survival in patients with gastric cancer. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.25, no.1, pp.83-88, 2006
• ÖZDEMİR F., BEKTAŞ Ö., Uruç I., BÜLBÜL Y., TOPBAŞ M., Kavgaci H., et al. The prognostic significance of pretreatment serum LDH level in non-small cell lung cancer Küçük hücreli dişi akciǧer kanserli hastalarda tedavi öncesi serum LDH düzeylerinin prognostik önemi. UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.15, no.3, pp.115-119, 2005
• Kavgaci H., REIS A., OZDEMIR F., BEKTAS Ö., ARSLAN M., AYDIN F. Carcinoma erysipelatoides resulting from gastric adenocarcinoma: An unusual clinical presentation. MEDICAL PRINCIPLES AND PRACTICE , vol.14, no.1, pp.61-63, 2005
• OZDEMIR F., YILMAZ M., AKDOGAN R. A., KAYNAR K., Kavgaci H., KARTI S., et al. Hodgkin's disease and autoimmune hemolytic anemia: A case report. MEDICAL PRINCIPLES AND PRACTICE , vol.14, no.3, pp.205-207, 2005
• ÖZDEMİR F., BEKTAŞ Ö., URUÇ İ., BÜLBÜL Y., TOPBAŞ M., KAVGACI H., et al. Küçük hücre dışı akciğer kanserli hastalarda tedavi öncesi serum LDH düzeylerinin prognostik önemi. Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi , 2005
• Kavgaci H., OZDEMIR F., OVALI E., YAVUZ A., YAVUZ M., AYDIN F. Effect of the farnesyl transferase inhibitor L-744,832 on the colon cancer cell line DLD-1 and its combined use with radiation and 5-FU. CHEMOTHERAPY , vol.51, no.6, pp.319-323, 2005
• OZDEMIR F., AYDIN F., YILMAZ M., Kavgaci H., BEKTAS Ö., YAVUZ M., et al. The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive Non-Hodgkin's Lymphoma (NHL). JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.23, no.3, pp.485-488, 2004
• OZDEMIR F., OVALI E., AYDIN F., Kavgaci H., BUYUKCELIK A., UCAR F., et al. The in-vitro effects of medroxyprogesterone acetate on acidic pH induced apoptosis of periferal blood mononuclear cells. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.23, no.1, pp.93-95, 2004
• OZDEMIR F., ESEN N., OVALI E., TEKELIOGLU Y., YILMAZ M., AYDIN F., et al. Effects of dexamethasone, all-trans retinoic acid, vitamin D-3 and interferon-alpha on FO myeloma cells. CHEMOTHERAPY , vol.50, no.4, pp.190-193, 2004
• Karti S. S., Eren N., SÖNMEZ M., YILMAZ M., ÇOBANOĞLU Ü., Kavgaci H., et al. Leiomyosarcoma of the uterus presenting with thrombotic thrombocytopenic purpura. Turkish Journal of Haematology , vol.20, no.3, pp.163-165, 2003
• OVALI E., OZDEMIR F., AYDIN F., Kavgaci H., TEKELIOGLU Y., BUYUKCELIK A., et al. The effects of dexamethasone on leukemic cells derived from patients with AML. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.22, no.1, pp.85-89, 2003
• EREM C., Kavgaci H., ERSOZ H. Ö., HACIHASANOGLU A., UKINC K., KARTI S., et al. Blood coagulation and fibrinolytic activity in hypothyroidism. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.57, no.2, pp.78-81, 2003
• AYDIN F., OZDEMIR F., Kavgaci H., YILMAZ M., KARTI S. The effects of medroxyprogesterone acetate on apoptosis of CD34+cells. CHEMOTHERAPY , vol.49, pp.66-70, 2003
• AYDIN F., YILMAZ M., OZDEMIR F., Kavgaci H., YAVUZ M., YAVUZ A. Correlation of serum IL-2, IL-6 and IL-10 levels with International Prognostic Index in patients with aggressive non-Hodgkin's lymphoma. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.25, no.6, pp.570-572, 2002
• Kavgaci H., OZDEMIR F., AYDIN F., YAVUZ A., YAVUZ M. Endogenous granulocyte colony-stimulating factor (G-CSF) levels in chemotherapy-induced neutropenia and in ;neutropenia related with primary diseases. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.21, no.4, pp.475-479, 2002
• Kavgaci H., SAHIN A., ERSOZ O., EREM C., OZDEMIR F. The effects of losartan and fosinopril diabetic patients in hypertensive type 2. DIABETES RESEARCH AND CLINICAL PRACTICE , vol.58, no.1, pp.19-25, 2002
• YAVUZ M., YAVUZ A., Aydin F., Can G., Kavgaci H. The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: A randomized controlled study. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.54, no.1, pp.195-202, 2002
• Erem C., Yildiz R., Kavgaci H., Karahan C., Deger O., Can G., et al. Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon city). DIABETES RESEARCH AND CLINICAL PRACTICE , vol.54, no.3, pp.203-208, 2001
• Erem C., Kavgaci H., Karahan C., Mocan M., Telatar M. Thyroid function tests in pregnant women with and without goiter in the eastern Black Sea region. GYNECOLOGICAL ENDOCRINOLOGY , vol.15, no.4, pp.293-297, 2001
• EREM C., USLU T., DEGER O., TOSUN M., Kavgaci H. Increased plasma lipoprotein (a) concentrations in Behcet's disease and its relation to vascular events. HEART , vol.84, no.2, pp.208-209, 2000
• Kapicioglu S., Baki A., Sari M., Ozdemir F., Kavgaci H. Does nimesulide induce gastric mucosal damage? "A double-blind randomized placebo-controlled trial". HEPATO-GASTROENTEROLOGY , vol.47, no.34, pp.1183-1185, 2000
• Baki A., Kapıcıoğlu S., TEKELİOĞLU Y., Kavgacı H., Reis A., Aydın F. Flowcytometric Analysis of helicobacter pylori on gastric mucosa. Medical Research , vol.17, no.2, pp.96-99, 1999 (Hakemli Dergi)
• YILDIRIM M., ULUSOY Ş., KAVGACI H. Diabetik Hiperfiltrasyon. Karadeniz Tıp Dergisi. , vol.7, no.2, pp.87-89, 1994 (Hakemli Dergi)
• KAVGACI H., EREM C., ULUSOY Ş., AYDIN F. Akut Böbrek Yetersizliğinin etyopatogenezi. T. Klin. Bilimleri. , vol.14, pp.235-238, 1994 (Hakemli Dergi)
• OVALI E., ÇETİNER M., ÖREM A., AYDIN F., KAVGACI H., ULUSOY Ş., et al. Alfa interferonun nötrofil adherans ingestion ve bakterisidal aktivite fonksiyonları üzerine etkisi. Anadolu Tıp Dergisi. , vol.15, no.1, pp.69-81, 1993 (Hakemli Dergi)
• AYDIN F., ULUSOY Ş., KAVGACI H., KARDEŞ B., MOCAN Z. Viral hepatit serolojisi. T. Klin. Tıp Bilimleri. , vol.12, pp.281-287, 1992 (Hakemli Dergi)
• Komsuoğlu B., EREM C., Çetinarslan B., KAVGACI H. hypertension in elderly patients. TÜRK KARDİYOLOJİ DERNEĞİ ARŞİVİ , vol.18, no.3, pp.223-230, 1990
• Yıldız B., ÖZDEMİR F., KAVGACI H., TEKİNBAŞ C., KAYNAR R. K., AYDIN F. Skuamöz Hücreli Meme Kanseri Olgusu. 1. Tıbbi Onkoloji Kongresi, Antalya, Türkiye, pp.54,
• ÖZDEMİR F., Reis A., Yıldız B., KAVGACI H., KAYNAR R. K., AYDIN F. Rektum ve Tiroid Karsinomu Metastazı Gösteren Lenf Nodu Olgusu,. 1. Tıbbi Onkoloji Kongresi, Antalya, Türkiye, pp.73,
• ÖZTÜRK TOPÇU T., KAVGACI H., ÖZDEMİR F., MENTEŞE A., ÖREM A., AYDIN F. Plasma Malondialdehyde and Ischemia-modified Albumin levels in breast cancer patients before and after adjuvant chemotherapy. 15th St. Gallen International Breast Cancer Conference, 15 - 18 Mart 2017,
• GÜREL DURMUŞ Z., ÖZSU S. S., ÖZLÜ T., ÖZTUNA F., TÜRKYILMAZ A., KAVGACI H. Endobronşiyal Metastaz yapan Renal Hücreli Karsinom olgusu’. 2. Ulusal Akciğer Sağlığı Kongresi, Antalya, Türkiye, 15 - 19 Mart 2017,
• AKSU ARICA D., ÖZTÜRK TOPÇU T., BAYKAL SELÇUK L., YAYLI S., seymen u., BAHADIR S., et al. Setuksimaba baglı akneiform erüpsiyunda demodex varlıgının degerlendirilmesi. 26. Ulusal Dermatoloji Kongresi, Türkiye, 19 - 23 Ekim 2016,
• AKSU ARICA D., ÖZTÜRK TOPÇU T., BAYKAL SELÇUK L., YAYLI S., SEYMAN Ü., FİDAN E., et al. Setuksimaba bağlı akneiform erüpsiyunda demodex varlığının değerlendirilmesi. 26. Ulusal Dermatoloji Kongresi, Türkiye, 19 - 23 Ekim 2016,
• AKSU ARICA D., öztürk topçu t., BAYKAL SELÇUK L., YAYLI S., SEYMAN Ü., fidan e., et al. setuksimaba bağlı akneiform erüpsiyonda demodex varlığının değerlendirilmesi. 26. ulusal dermatoloji kongresi, Antalya, Türkiye, 19 - 23 Ekim 2016, pp.34,
• KARAMAN E., KAVGACI H., KAZAZ İ. O., MUNĞAN S., KOÇ E. MİDE TAŞLI YÜZÜK HÜCRELİ KARSİNOMUNUN MESANE METASTAZI. 6. TÜRK TIBBİ ONKOLOJİ KONGRESİ, Antalya, Türkiye, 23 Mart 2016 - 27 Ocak 2017, pp.574,
• BAHAT Z., KANDAZ M., MEMİŞ Y., CANYILMAZ E., KAVGACI H., YÖNEY A. ÇERNOBİLDEN 25 YIL SONRA DOĞU KARADENİZ BÖLGESİNDE MULTİPLE PRİMER KANSERLER:TEK MERKEZ ÇALIŞMASI. 21.ULUSAL KANSER KONGRESİ, Antalya, Türkiye, 22 - 26 Nisan 2015,
• BAHAT Z., KANDAZ M., CANYILMAZ E., MEMIS Y. H., KAVGACI H., YÖNEY A. Çernobilden 25 Yıl Sonra Doğu Karadeniz Bölgesinde Multiple Primer Kanserler; Tek Merkez Çalışması. XXI ULUSAL KANSER KONGRESİ, Antalya, Türkiye, 22 - 26 Nisan 2015, pp.645,
• KOŞUCU P., ŞAKİR S., KAVGACI H., AKİLE K., KÜPELİ A., KOŞUCU M. Dynamic contrast enhanced MRI in benign and malignant sclerotic bone lesions. EURUPEAN CONGRES OF RADİOLOGY, 5 - 07 Mart 2015,
• BEYHUN N. E., ÇAN G., TİRYAKİ A., KARAKULLUKÇU S., BULUT B., YEŞİLBAŞ ÜÇÜNCÜ Ş., et al. “Kanser Hastalarının İhtiyaçları Temelinde Oluşan Biyopsikososyal Stres Ölçeği’nin Türkçe Geçerlik-Güvenirlik Çalışması”. 17. ULUSAL HALK SAĞLIĞI KONGRESİ, Edirne, Türkiye, 20 - 24 Ekim 2014, pp.147,
• Aydin F., Topcu T. O., Ozdemir F., Sahin N. O., Kavgaci H., Kandaz M. Pazopanib for the treatment of metastatic nonadipocytic soft-tissue sarcoma.. 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, vol.32,
• AYDIN F., TOPÇU T. O., ÖZDEMİR F., ŞAHİN N. O., KAVGACI H., KANDAZ M. PAZOPANİB FOR THE TREATMENT OF METASTATİC NONADİPOCYTİC SOFT-TİSSUE SARCOMA. ASCO ANNUAL MEETING ABSTRACTS, Amerika Birleşik Devletleri, 20 Mayıs 2014,
• ÖZDEMİR F., Ersoy K., TOPBAŞ M., FİDAN E., Yildiz B., Kavgaci H., et al. The effect of prenatal factors on the development of colon cancer. European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, vol.49,
• Fidan E., Yildiz B., Yilmaz M., Ozdemir F., Kavgaci H., Aydin F. INCREASED CIRCULATING VITAMIN D AND TESTOSTERONE LEVELS IN PATIENTS WITH CANCER. 35th European-Society-for-Medical-Oncology (ESMO) Congress, Milan, İtalya, 8 - 12 Ekim 2010, vol.21, pp.161,
• Ozdemir F., Ozdemir S., Yildiz B., Fidan E., Kavgaci H., Aydin F. The effects of prenatal factors on the development of non-small cell lung cancer. 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, Berlin, Almanya, 20 - 24 Eylül 2009, vol.7, pp.515,
• Kavgaci H., Yildiz B., Fidan E., Reis A., Ozdemir F., Cobanoglu U., et al. The effects of E-Cadherin and bcl-2 on prognosis in patients with breast cancer. 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, Berlin, Almanya, 20 - 24 Eylül 2009, vol.7, pp.307-308,
• Ozdemir F., Ersoy K., Topbas M., Fidan E., Yildiz B., Kavgaci H., et al. The effect of prenatal factors on the development of colon cancer. 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, Berlin, Almanya, 20 - 24 Eylül 2009, vol.7, pp.204,
• GONCA H. U., CANYILMAZ E., ZENGİN A. Y., YAVUZ M. N., KAVGACI H. Memede skuamöz Hücreli Olgu Sunumu. XVII. Ulusal Kanser Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2007
• USLU G. H., CANYILMAZ E., ZENGIN A. Y., YAVUZ M. N., KAVGACI H. Memede squamöz hücreli olgu sunumu. XVII. Ulusal Kanser Kongresi, Antalya, Türkiye, 21 - 25 Nisan 2007, pp.8,
• ÖZDEMİR F., AKAGÜN T., YILDIZ B., KAVGACI H., TEKİNBAŞ C., AYDIN F. Diffüz dev karaciğer metastazı olan mide kanseri olgusu. I. TIBBİ ONKOLOJİ KONGRESİ, Türkiye, 29 Mart - 02 Nisan 2006,
• Aydin F., Ozdemir F., Akdogan R., Reis A., Kavgaci H. The effects of VEGF and VEGFR-2 on survival inpatients with gastric cancer.. 41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, vol.23,
• ÖZDEMİR F., BEKTAŞ Ö., URUÇ İ., BÜLBÜL Y., TOPBAŞ M., KAVGACI H., et al. Küçük hücre dışı akciğer kanserli hastalarda tedavi öncesi serum LDH düzeylerinin prognostik önemi. 1. Ulusal akciğer kanseri kongresi. İstanbul, Türkiye, 25 - 28 Kasım 2004